Clinical Trials Logo
  1. Home
  2. Facial Rhytides
  3. NCT01777620

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

Facial Rhytides Clinical Trial

Clinical Trial Summary

This is a safety and efficacy study of BOTOX® in subjects with facial rhytides (glabellar lines and crow's feet lines).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01777620
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 4
Start date January 31, 2013
Completion date July 31, 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT01189760 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02261493 - A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides Phase 3
Completed NCT01224015 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02176356 - Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study) Phase 4
Completed NCT01600729 - Reliability of the Facial Wrinkle Scale in Japanese Subjects N/A
Completed NCT01391299 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines N/A
Completed NCT00842062 - Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation Phase 1/Phase 2
Completed NCT04609020 - Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment Phase 4
Completed NCT01299103 - Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles N/A
Completed NCT01608659 - An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A